Current Cancer Therapy Reviews
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 2
Author(s): Ronald M. Bukowski
Affiliation:
Export Options
About this article
Cite this article as:
Bukowski M. Ronald , Meet Our Editorial Board Member, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/157339471402180712111844
DOI https://dx.doi.org/10.2174/157339471402180712111844 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
22
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel 3-(1-(2-(2,7a-dihydrobenzo[d]thiazol-2-ylthio)acetyl)-5-substitutedphenyl-4,5-dihydro-1H-pyrazol-3-yl)-Coumarins: Synthesis and Anticancer Activity
Letters in Drug Design & Discovery Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Developmental Changes in the Roles of Patients and Families in Type 1 Diabetes Management
Current Diabetes Reviews The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Rational Design and Optimization of Trypsin Inhibitory Peptides with Antibacterial Activity
Current Computer-Aided Drug Design Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo
Anti-Cancer Agents in Medicinal Chemistry Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in PUVA Photochemotherapy and PDT for the Treatment of Cancer
Current Pharmaceutical Design PreQ<sub>0</sub> Base, an Unusual Metabolite with Anti-cancer Activity from Streptomyces qinglanensis 172205
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Pharmaceutical Design Plant Cells as Pharmaceutical Factories
Current Pharmaceutical Design Study of Parasitic Infections, Cancer, and other Diseases with Mass-Spectrometry and Quantitative Proteome-Disease Relationships
Current Proteomics Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease
Current Topics in Medicinal Chemistry Optimize Administration Protocol of Capecitabine Plus Docetaxel Combination in Metastatic Breast Cancer Patients
Current Topics in Medicinal Chemistry Topical Antimicrobials for Burn Wound Infections
Recent Patents on Anti-Infective Drug Discovery Editorial from Guest Editor [Hot Topic: Lung Cancer, What is New? (Guest Editor: Edward Yu)]
Current Respiratory Medicine Reviews Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases
Current Topics in Medicinal Chemistry Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets
Current Topics in Medicinal Chemistry Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?
Current Cancer Drug Targets